Meta-analysis of the connection between glutathione S-transferase T1 null/presence gene polymor
Conditional Lpar1 gene concentrating on identifies cell sorts mediating neuropathic ache
LPA1 is one among six recognized receptors (LPA1-6) for lysophosphatidic acid (LPA). Constitutive Lpar1 null mutant mice have been instrumental in figuring out roles for LPA-LPA1 signaling in neurobiological processes, mind growth, and conduct, in addition to modeling human neurological ailments like neuropathic ache. Constitutive Lpar1 null mutant mice are protected against partial sciatic nerve ligation (PSNL)-induced neuropathic ache, nevertheless, the cell sorts which can be functionally liable for mediating this protecting impact are unknown.
Right here, we report the technology of an Lpar1flox/flox conditional null mutant mouse that permits for cre-mediated conditional deletion, mixed with a PSNL ache mannequin. Lpar1flox/flox mice had been crossed with cre transgenic strains pushed by neural gene promoters for nestin (all neural cells), synapsin (neurons), or P0 (Schwann cells). CD11b-cre transgenic mice had been additionally used to delete Lpar1 in microglia.
PSNL-initiated ache responses had been decreased following cre-mediated Lpar1 deletion with all three neural promoters in addition to the CD11b promoter, supporting involvement of Schwann cells, central and/or peripheral neurons, and microglia in mediating ache. Curiously, rescue responses had been nonidentical, implicating distinct roles for Lpar1-expressing cell sorts. Our outcomes with a brand new Lpar1 conditional mouse mutant increase an understanding of LPA1 signaling within the PSNL mannequin of neuropathic ache.

Human MIG |
|||
| HC77725 | Antigenix America | 20 µg | Ask for price |
Anti-Human MIG Antibody |
|||
| 101-M78 | ReliaTech | 500 µg | 246.75 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant murine MIG is a 12.2 kDa protein containing 105 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Anti-Human MIG Antibody |
|||
| 102-P62 | ReliaTech | 100 µg | 245.7 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Anti-Human MIG (CXCL9) |
|||
| MBS550702-01mg | MyBiosource | 0.1mg | 260 EUR |
Anti-Human MIG (CXCL9) |
|||
| MBS550702-02mg | MyBiosource | 0.2mg | 335 EUR |
Mouse Anti-Human MIG |
|||
| MBS690197-05mg | MyBiosource | 0.5mg | 525 EUR |
Mouse Anti-Human MIG |
|||
| MBS690197-5x05mg | MyBiosource | 5x0.5mg | 2080 EUR |
Anti-Human MIG - Biotin |
|||
| RHF451B | Antigenix America | 50 µg | Ask for price |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-006mL | MyBiosource | 0.06mL | 335 EUR |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-012mL | MyBiosource | 0.12mL | 520 EUR |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-02mL | MyBiosource | 0.2mL | 800 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-0005mg | MyBiosource | 0.005mg | 300 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-002mg | MyBiosource | 0.02mg | 450 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-5x002mg | MyBiosource | 5x0.02mg | 1725 EUR |
MIG Human, His |
|||
| PT-A03611 | Novatein Biosciences, Inc. |
|
|
MIG/CXCL9, Human |
|||
| HY-P7253 | MedChemExpress | 10ug | 321.6 EUR |
MIG, CXCL9, human |
|||
| RC312-20 | Bio Basic | 5ug | 125.26 EUR |
Human MIG Recombinant |
|||
| MBS553131-0005mg | MyBiosource | 0.005mg | 165 EUR |
Human MIG Recombinant |
|||
| MBS553131-002mg | MyBiosource | 0.02mg | 245 EUR |
MIG, human recombinant |
|||
| 4240-1000 | Biovision | each | 5475.6 EUR |
MIG, human recombinant |
|||
| 4240-20 | Biovision | each | 346.8 EUR |
anti- MIG antibody |
|||
| FNab05188 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against MIG |
|||
PE anti-human CXCL9 (MIG) |
|||
| GT13975 | Sony | 100 Tests | Ask for price |
PE anti-human CXCL9 (MIG) |
|||
| GT13974 | Sony | 25 Tests | Ask for price |
APC anti-human CXCL9 (MIG) |
|||
| GT13976 | Sony | 25 Tests | Ask for price |
APC anti-human CXCL9 (MIG) |
|||
| GT13977 | Sony | 100 Tests | Ask for price |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-01mg | MyBiosource | 0.1mg | 375 EUR |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-5x01mg | MyBiosource | 5x0.1mg | 1390 EUR |
Human MIG ELISA Kit |
|||
| GWB-SKR051 | GenWay Biotech | 96 Tests | Ask for price |
Human MIG ELISA Kit |
|||
| NP-E10048 | Novatein Biosciences, Inc. |
|
|
Human MIG ELISA Kit |
|||
| SEKH-0245 | Solarbio Life Science |
|
|
CXCL9 / MIG (74-103) (Human) |
|||
| 045-62 | PHOENIX PEPTIDE | 100 μg | 289.44 EUR |
CXCL9 / MIG (77-103) (Human) |
|||
| 045-63 | PHOENIX PEPTIDE | 100 μg | 257.04 EUR |
MIG (Human) ELISA Kit |
|||
| EKA51867-5x96T | Biomatik Corporation | 5x96T | Ask for price |
MIG (Human) ELISA Kit |
|||
| EKA51867-96T | Biomatik Corporation | 96T | 446.9 EUR |
Human MIG Construction Kit |
|||
| RHF450CK | Antigenix America | 960 Tests | Ask for price |
Human CXCL9 (MIG) ELISA |
|||
| GWB-CXCL9E | GenWay Biotech | 96 well | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02002 | CHI Scientific | 5µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02003 | CHI Scientific | 20µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02004 | CHI Scientific | 1mg | Ask for price |
Human MIG (CXCL9), (Recombinant) |
|||
| 22060423-1 | Bio-WORLD | 5 µg | 190.94 EUR |
Recombinant Human MIG (CXCL9) |
|||
| HECXP-0901 | Cyagen | 5ug | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-002mg | MyBiosource | 0.02mg | 385 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-1mg | MyBiosource | 1(mg) | 4600 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-5x1mg | MyBiosource | 5x1mg | 20445 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-0005mg | MyBiosource | 0.005mg | 240 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-002mg | MyBiosource | 0.02mg | 310 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-1mg | MyBiosource | 1mg | 2880 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-5x1mg | MyBiosource | 5x1mg | 12630 EUR |
Recombinant Human MIG/CXCL9 |
|||
| P1213-.005 | ApexBio | 5ug | 108.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.1 | ApexBio | 100ug | 900.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.5 | ApexBio | 500ug | 2020.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100665 | ABM | 20 µg | 235 EUR |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100669 | ABM | 1.0 mg | 3900 EUR |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG/CXCL9 |
|||
| P6524-100μg | Beyotime Biotech Inc | 100 µg | Ask for price |
Recombinant Human MIG/CXCL9 |
|||
| P6524-500μg | Beyotime Biotech Inc | 500 µg | Ask for price |
Recombinant Human MIG/CXCL9 |
|||
| P6524-5μg | Beyotime Biotech Inc | 5 μg | Ask for price |
Anti- Monokine Induced by IFN-gamma (MIG) Human Antibody |
|||
| GWB-B1A431 | GenWay Biotech | 0.1 mg | Ask for price |
MIG/CXCL9 Protein, Human |
|||
| UA040222 | Starter Biotechnology Co Ltd |
|
|
CXCL9 / MIG, recombinant (Human) |
|||
| 033-15 | PHOENIX PEPTIDE | 10 μg | 390.96 EUR |
Recombinant Human CXCL9 (MIG) |
|||
| 6565 | Immunochemistry | 5 µg | 194 EUR |
MIG/CXCL9 (Recombinant) Human |
|||
| GWB-4B8A74 | GenWay Biotech | 0.02 mg | Ask for price |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-0005mg | MyBiosource | 0.005mg | 305 EUR |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-5x0005mg | MyBiosource | 5x0.005mg | 1210 EUR |
MIG Human Recombinant (CXCL9) |
|||
| rAP-0213 | Angio Proteomie | Inquiry | Ask for price |
Human CXCL9/MIG Antibody Pair Set |
|||
| ABPR-ZB074 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human CXCL9/MIG |
|||
Anti-Human MIG Rabbit Polyclonal Antibody |
|||
| TA328386 | Origene Technologies GmbH | 100 µg | Ask for price |
Sheep Polyclonal anti-Human CXCL9 (MIG) |
|||
| hAP-5823 | Angio Proteomie | 50ug | 400 EUR |
Mouse Monoclonal anti-human CXCL9 (MIG) |
|||
| hAP-0220 | Angio Proteomie | 100ug | 250 EUR |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-01mg | MyBiosource | 0.1mg | 405 EUR |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-5x01mg | MyBiosource | 5x0.1mg | 1520 EUR |
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.48 | EnoGene | 48T | 295 EUR |
|
Description: 8pg/ml |
|||
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.96 | EnoGene | 96T | 395 EUR |
|
Description: 8pg/ml |
|||
Human MIG/CXCL9 ELISA Kit |
|||
| E16HE0067 | EnoGene | 96T | 833.33 EUR |
Human MIG/CXCL9 ELISA KIT |
|||
| E42EH-272 | EnoGene | 96T/48T | 795 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-48Tests | MyBiosource | 48Tests | 390 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-5x96Tests | MyBiosource | 5x96Tests | 2275 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-96Tests | MyBiosource | 96Tests | 495 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| RK04210 | Abclonal | 96T | 322.37 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| RK00126 | Abclonal | 96 Tests | 322.37 EUR |
Human MIG / CXCL9 GENLISA ELISA |
|||
| KBH0049 | Krishgen | 1 x 96 wells | 286 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| E28L0571 | EnoGene | 96T | 666.67 EUR |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-5x96Tests | MyBiosource | 5x96Tests | 2680 EUR |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-96Tests | MyBiosource | 96Tests | 590 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-5x96Tests | MyBiosource | 5x96Tests | 2200 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-96Tests | MyBiosource | 96Tests | 480 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| NR-E10150 | Novatein Biosciences, Inc. |
|
|
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-1x96Wells | MyBiosource | 1x96Wells | 520 EUR |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-5x96Wells | MyBiosource | 5x96Wells | 2395 EUR |
Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| JOT-PR1091 | Jotbody | 5µg | 205 EUR |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of >1 x 104 IU/mg. |
|||
Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| PR1091 | Bioworld Biotech | 5µg | 158 EUR |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of >1 x 104 IU/mg. |
|||
MIG (Human) Sandwich ELISA Kit |
|||
| OK-0150 | Assay Biotech | 1Kit | 217 EUR |
|
Description: MIG (Human) Colorimetric Sandwich ELISA Kit |
|||
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-1x96Wells | MyBiosource | 1x96Wells | 500 EUR |
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-5x96Wells | MyBiosource | 5x96Wells | 2300 EUR |
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072 | ReliaTech | 20 µg | 196.35 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072S | ReliaTech | 5 µg | 92.4 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Recombinant Human MIG/CXCL9 protein |
|||
| CD01286-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | 176 EUR |
|
Description: CXCL9 is a T-cell chemoattractant induced by IFN-γ belonging to the CXC chemokine family and it is also known as Monokine induced by gamma interferon (MIG). CXCL9 is closely related to two other CXC chemokines called CXCL10 and CXCL11 and they all elicit their chemotactic functions by interacting with the chemokine receptor CXCR3. CXCL9 is a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response and chemotactic for activated T-cells. Recombinant human CXCL9 contains 103 amino acids which is a single non-glycosylated polypeptide chain. The human CXCL9 shares 75 % and 67 % a.a. sequence identity with mouse and rat CXCL9. |
|||
Recombinant Human MIG (CXCL9) Protein |
|||
| PROTQ07325-2 | BosterBio | 20ug | 380.4 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Purified recombinant Human MIG protein |
|||
| MBS5308825-002mg | MyBiosource | 0.02mg | 435 EUR |
Purified recombinant Human MIG protein |
|||
| MBS5308825-5x002mg | MyBiosource | 5x0.02mg | 1905 EUR |
Recombinant Human (E.Coli) MIG (CXCL9) |
|||
| RP-1035 | Alpha Diagnostics | 5 ug | 196.8 EUR |
Human MIG Recombinant Protein Lyophilized |
|||
| IHUMIGRLY5UG | Innovative research | each | 341 EUR |
|
Description: Human MIG Recombinant Protein Lyophilized |
|||
Human MIG Recombinant Protein Lyophilized |
|||
| MBS8432766-INQUIRE | MyBiosource | INQUIRE | Ask for price |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-0005mg | MyBiosource | 0.005mg | 160 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-005mg | MyBiosource | 0.05mg | 290 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-1mg | MyBiosource | 1mg | 2200 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-5x1mg | MyBiosource | 5x1mg | 9755 EUR |
Human CXCL9/MIG Recombinant Protein |
|||
| PROTQ07325 | BosterBio | Regular: 20ug | 250 EUR |
|
Description: Human CXCL9/MIG Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 23-125aa. Application(s): SDS-PAGE. |
|||
MIG Human Recombinant Protein (CXCL9) |
|||
| PROTQ07325-1 | BosterBio | Regular: 20ug | 380.4 EUR |
|
Description: MIG (monokine induced by gamma-interferon ) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 103 amino acids and having a molecular mass of 11700 Dalton. The MIG is purified by proprietary chromatographic techniques. |
|||
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535 | Creative Diagnostics | 1 mg; 5 mg | Ask for price |
|
Description: Armenian Hamster |
|||
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-1mg | Creative Diagnostics | 1 mg | 1076.4 EUR |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-5mg | Creative Diagnostics | 5 mg | 2886 EUR |
Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0055 | GenWay Biotech | 1 kit | Ask for price |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-0005mg | MyBiosource | 0.005mg | 240 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-002mg | MyBiosource | 0.02mg | 310 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-1mg | MyBiosource | 1mg | 3815 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-5x1mg | MyBiosource | 5x1mg | 16840 EUR |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-01mg | MyBiosource | 0.1mg | 320 EUR |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-5x01mg | MyBiosource | 5x0.1mg | 1390 EUR |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| TA354753 | Origene Technologies GmbH | 100 µg | Ask for price |
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | 275 EUR |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | 823 EUR |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
OKAG00051-96W - MIG ELISA Kit (Human) |
|||
| OKAG00051-96W | Aviva Systems Biology | 1plate:12x8-WellMicrostrips | 500 EUR |
OKRC00714-96W - MIG ELISA Kit (Human) |
|||
| OKRC00714-96W | Aviva Systems Biology | 96Wells | 525 EUR |
MIG Human Recombinant (CXCL9), His Tag |
|||
| rAP-0212 | Angio Proteomie | Inquiry | Ask for price |
CXCL9 / MIG, recombinant (Human) - ELISA Kit |
|||
| EK-033-15 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
MIG Antibody |
|||
| C30114-100ul | Assay Biotech | 100μl | 217 EUR |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG Antibody |
|||
| C30114-50ul | Assay Biotech | 50μl | 143.5 EUR |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG antibody |
|||
| MBS532154-05mg | MyBiosource | 0.5mg | 370 EUR |
MIG antibody |
|||
| MBS532154-5x05mg | MyBiosource | 5x0.5mg | 1525 EUR |
MIG antibody |
|||
| MBS534409-005mg | MyBiosource | 0.05mg | 465 EUR |
MIG antibody |
|||
| MBS534409-01mg | MyBiosource | 0.1mg | 575 EUR |
MIG antibody |
|||
| MBS534409-5x01mg | MyBiosource | 5x0.1mg | 2430 EUR |
MIG antibody |
|||
| 10R-M169A | Fitzgerald Industries International | 500 ug | Ask for price |
MIG antibody |
|||
| 70R-MR007 | Fitzgerald Industries International | 50 ug | Ask for price |
MIG Antibody |
|||
| ASA-B1277 | Novatein Biosciences, Inc. | 1 Each | Ask for price |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-15Plates | MyBiosource | 15Plates | 600 EUR |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5Plates | MyBiosource | 5Plates | 345 EUR |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5x15Plates | MyBiosource | 5x15Plates | 2755 EUR |
mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
mig-38 Antibody |
|||
| CSB-PA898913XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-38 protein |
|||
mig-38 Antibody |
|||
| CSB-PA898913XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-38 protein |
|||
MIG |
|||
| chm-333 | ProSpec Tany | 5µg | 60 EUR |
|
Description: Recombinant Human MIG (CXCL9) |
|||
Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-01mL | MyBiosource | 0.1mL | 595 EUR |
Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-5x01mL | MyBiosource | 5x0.1mL | 2500 EUR |
Nori® Human CXCL9/MIG ELISA Kit |
|||
| GR106310 | Genorise Scientific | 96-well | 461 EUR |
Anti Mouse CXCL9 Mab [MIG-2F5-5] |
|||
| 831043 | Antibody Research Corporation | 100 µg | Ask for price |
mig-5 Antibody |
|||
| CSB-PA437276XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-5 protein |
|||
mig-5 Antibody |
|||
| CSB-PA437276XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-5 protein |
|||
mig-6 Antibody |
|||
| CSB-PA017431XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-6 protein |
|||
mig-6 Antibody |
|||
| CSB-PA017431XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-6 protein |
|||
Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | 188 EUR |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | 517 EUR |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
MIG ELISA Kit (Human) : 96 Wells (OKAG00051) |
|||
| OKAG00051 | Aviva Systems Biology | 96 Wells | 715.2 EUR |
|
Description: Description of target: This antimicrobial gene encodes a protein thought to be involved in T cell trafficking. The encoded protein binds to C-X-C motif chemokine 3 and is a chemoattractant for lymphocytes but not for neutrophils.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 16 pg/mL |
|||
Biotinylated Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0059 | GenWay Biotech | 1 kit | Ask for price |
MIG (CXCL9) (NM_002416) Human Over-expression Lysate |
|||
| E45H06179-2 | EnoGene | each | 395 EUR |
MIG (CXCL9) (NM_002416) Human Over-expression Lysate |
|||
| LS004283 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of chemokine (C-X-C motif) ligand 9 (CXCL9) |
|||
Human MIG Construction Kit w/Developing Reagents |
|||
| RHF450CKC | Antigenix America | - | Ask for price |
Recombinant Human CXCL9/MIG Protein, His Tag |
|||
| E40KMH960 | EnoGene | 20ug | 495 EUR |
CXCL9 / MIG, recombinant (Human) - I-125 Labeled |
|||
| T-033-15 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Recombinant Human CXCL9/MIG Protein, His Tag |
|||
| KMH960 | KMD Bioscience | 50 µg | Ask for price |
Mig-7 (MIG7) Antibody |
|||
| abx339505-100l | Abbexa | 100 µl | 350 EUR |
Mig-7 (MIG7) Antibody |
|||
| 20-abx339505 | Abbexa |
|
|
Mig-7 (MIG7) Antibody |
|||
| abx339505-50l | Abbexa | 50 µl | 250 EUR |
Mig-7 (MIG7) Antibody |
|||
| abx211094-100l | Abbexa | 100 µl | 350 EUR |
Mig-7 (MIG7) Antibody |
|||
| 20-abx211094 | Abbexa |
|
|
Mig-7 (MIG7) Antibody |
|||
| abx211094-50l | Abbexa | 50 µl | 250 EUR |
MIG Mouse Recombinant (CXCL9) (MIG Mouse) |
|||
| PT_41526 | Novatein Biosciences, Inc. |
|
|
Human MIG "Super-X" Pre-Coated ELISA Kit |
|||
| RHF450CKX | Antigenix America | - | Ask for price |
Human MIG "Super-X" Pre-Coated ELISA Kit |
|||
| RHF450CKX1 | Antigenix America | - | Ask for price |
Human MIG "Super-X" Pre-Coated ELISA Kit |
|||
| RHF450CKX2 | Antigenix America | - | Ask for price |
Mouse Anti-Human CXCL9/MIG monoclonal antibody, clone NN17 |
|||
| CABT-ZB499 | Creative Diagnostics | 50 μl | 595 EUR |
|
Description: Mouse |
|||
Rabbit Anti-Human CXCL9/MIG monoclonal antibody, clone S161 |
|||
| CABT-ZB871 | Creative Diagnostics | 50 μl | 520 EUR |
|
Description: Rabbit |
|||
An up to date meta-analysis of the connection between glutathione S-transferase T1 null/presence gene polymorphism and the chance of lung most cancers
Goal of examine: There have been many experiences revealed on the connection between glutathione S-transferase T1 (GSTT1) null/presence gene polymorphism and the chance of lung most cancers in these years. In earlier, we carried out a meta-analysis to guage the connection between GSTT1 null/presence gene polymorphism and the chance of lung most cancers. This examine was carried out to replace it.
Supplies and strategies: The affiliation research had been recognized from PubMed and Cochrane Library on March 1, 2016.
Outcomes: Sixty-three experiences had been recruited into this meta-analysis for the affiliation of null genotype of GSTT1 with lung most cancers susceptibility, consisting of 21,220 sufferers with lung most cancers and 21,496 controls.
There was a marked affiliation between GSTT1 null genotype and lung most cancers threat in general populations and in Asians (general populations: Odds ratio [OR] = 1.17, 95% confidence interval [95% CI]: 1.07-1.28, P = 0.006; Asians: OR = 1.41, 95% CI: 1.23-1.62, P < 0.00001). Nevertheless, GSTT1 null genotype was not related to the chance of lung most cancers in Caucasians, Brazilian inhabitants, and Africans.
Conclusion: GSTT1 null genotype is related to the lung most cancers threat in general populations and in Asians.
International evaluation of SBP gene household in Brachypodium distachyon reveals its affiliation with spike growth
SQUAMOSA-promoter binding like proteins (SBPs/SPLs) are plant particular transcription elements focused by miR156 and concerned in varied organic pathways, taking part in multi-faceted developmental roles. This gene household will not be nicely characterised in Brachypodium. We recognized a complete of 18 SBP genes in B. distachyon genome. Phylogenetic evaluation revealed that SBP gene household in Brachypodium expanded via massive scale duplication.
A complete of 10 BdSBP genes had been recognized as targets of miR156. Transcript cleavage evaluation of chosen BdSBPs by miR156 confirmed their antagonistic connection. Various splicing was noticed taking part in an necessary position in BdSBPs and miR156 interplay.
Characterization of T-DNA Bdsbp9 mutant confirmed decreased plant development and spike size, reflecting its involvement within the spike growth. Expression of a majority of BdSBPs elevated throughout spikelet initiation. Particularly, BdSBP1 and BdSBP3 differentially expressed in response to vernalization. Differential transcript abundance of BdSBP1, BdSBP3, BdSBP8, BdSBP9, BdSBP14, BdSBP18 and BdSBP23 genes was noticed throughout the spike growth underneath excessive temperature.
Co-expression community, protein-protein interplay and organic pathway evaluation point out that BdSBP genes primarily regulate transcription, hormone, RNA and transport pathways. Our work reveals the multi-layered management of SBP genes and demonstrates their affiliation with spike growth and temperature sensitivity in Brachypodium.
Rat Monoclonal anti-mouse CCL-6 |
|||
| mAP-0340 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-Human CCL-11 |
|||
| hAP-0136 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-Human CCL-11 |
|||
| hAP-0136A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-28 |
|||
| hAP-0153 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-28 |
|||
| hAP-0153A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-Human CCL-1 |
|||
| hAP-0135 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-22 (MDC) |
|||
| hAP-0147 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-17 (TARC) |
|||
| hAP-0141 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-17 (TARC) |
|||
| hAP-0141A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-18 (PARC) |
|||
| hAP-0142 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-25 (TECK) |
|||
| hAP-0150 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-27 (CTACK) |
|||
| hAP-0152 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-27 (CTACK) |
|||
| hAP-0152A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-21 (6Ckine) |
|||
| hAP-0146 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-24 (Eotaxin) |
|||
| hAP-0149 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-5 (RANTES) |
|||
| hAP-0155 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-5 (RANTES) |
|||
| hAP-0155A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-13 (MCP-4) |
|||
| hAP-0137 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-16 (HCC-4) |
|||
| hAP-0140 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-23 (MPIF-1) |
|||
| hAP-0148 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-23 (MPIF-1) |
|||
| hAP-0148A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-26 (Eotaxin-3) |
|||
| hAP-0151 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-2 (MCP-1) |
|||
| hAP-0144 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-7 (MCP-3) |
|||
| hAP-0156 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-8 (MCP-2) |
|||
| hAP-0157 | Angio Proteomie | 100ug | 250 EUR |
Anti-Mouse CCL-11 Antibody |
|||
| 103-M321 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL11 is a potent eosinophil chemoattractant that was originally purified from bronchoalveolar lavage fluid of guinea pigs sensitized by aerosol challenge with ovalbumin. Mouse CCL11 cDNA encodes a 97 amino acid (aa) precursor protein from which the aminoterminal 23 aa are cleaved to generate the 74 aa mature mouse CCL11. At the protein sequence level, mature mouse CCL11 is approximately 60% identical to mature human and guinea pig CCL11. In addition, mouse CCL11 also shows high aa sequence identity to members of the MCP family. Mouse CCL11 is chemotactic for eosinophils, but not mononuclear cells or neutrophils. CCL11 mRNA is expressed in a variety of tissues. The expression of CCL11 mRNA is induced in cultured endothelial cells in response to IFNγ. In addition, CCL11 mRNA is also induced in response to the transplantation of IL4secreting tumor cells. The CC chemokine receptor 3 (CCR3) has been identified as a specific human CCL11 receptor. |
|||
Anti-Mouse CCL-12 Antibody |
|||
| 103-M322 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL12 is a cloned mouse CC chemokine most closely related to human MCP1 (66% amino acid (aa) sequence identity in the mature protein). Mouse CCL12 encodes a 104 aa residue precursor protein with a 22 aa residue predicted hydrophobic signal sequence that is cleaved to generate a 82 aa residue mature protein. CCL12 is expressed constitutively in the thymus and lymph nodes. Under inflammatory conditions, CCL12 expression is also induced in activated macrophages and mast cells. The gene for mouse MCP1 has been mapped to the CC chemokine cluster on chromosome 11. Recombinant CCL12 has been shown to be a potent chemoattractant for monocytes and lymphocytes but not neutrophils. At high concentrations, CCL12 will also chemoattract eosinophils. CCL12 has been found to be a functional ligand for CCR2 but not CCR1, CCR3, or CCR5. |
|||
Anti-Mouse CCL-17 Antibody |
|||
| 103-M323 | ReliaTech | 100 µg | 399 EUR |
|
Description: Human thymus and activationregulated chemokine (TARC) also known as CCL17, is a novel CC chemokine identified using a signal sequence trap method. Mouse CCL17 was discovered as a dendritic cell (DC) specific gene by differentiation RNA display. Mouse CCL17 cDNA encodes a highly basic 93 amino acid (aa) residue precursor protein with a 23 aa residue putative signal peptide that is cleaved to generate the 70 aa residue mature secreted protein. Among CC chemokine family members, CCL17 has approximately 24-29% amino acid sequence identity with RANTES, MIP1α, MIP1β, MCP1, MCP2, MCP3, and I309. The gene for human CCL17 has been mapped to chromosome 16q13 rather than chromosome 17 where the genes for many human CC chemokines are clustered. Mouse CCL17 is constitutively expressed in thymic DC, and at a lower level in lymph node DC in the lung. Recombinant CCL17 has been shown to be chemotactic for T cell lines and antigen-primed T helper cells. In humans, CCL17 was identified to be a specific functional ligand for CCR4 and CCR8, receptors that are selectively expressed on T cells. |
|||
Anti-Mouse CCL-19 Antibody |
|||
| 103-M324 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL19/MIP3β, also known as ELC (EBI1Ligand Chemokine), is a β chemokine that binds specifically to the chemokine receptor CCR7/EBI1/ BLR2. Mouse (human) CCL19 cDNA encodes a 108 (98) amino acid precursor protein with a predicted 25 (21) aa signal peptide that is cleaved to form the 83 (77) aa mature secreted protein. CCL19 is distantly related to other β chemokines (20-30% aa sequence identity). Mouse CCL19 shares 83% aa sequence homology with human CCL19. CCL19 has been shown to be constitutively expressed in various lymphoid tissues (including thymus, lymph nodes, appendix, and spleen) in dendritic cells within the T-cell zone. The expression of CCL19 is downregulated by the antiinflammatory cytokine IL10. Recombinant CCL19 has been shown to be chemotactic for Tcells and Bcells. The CCL19 receptor (CCR7/ EBI1/ BLR2) is expressed in various lymphoid tissues and activated B and T lymphocytes. CCR7 is also strongly upregulated in Bcells infected with EpsteinBarr virus and T-cells infected with herpesvirus 6 or 7. |
|||
Anti-Mouse CCL-20 Antibody |
|||
| 103-M326 | ReliaTech | 100 µg | 399 EUR |
|
Description: Macrophage inflammatory protein 3 alpha (MIP-3α) is a member of the CC chemokine superfamily and has been designated CCL20. CCL20 is a β chemokine that is strongly up-regulated by inflammatory signals and down-regulated by the anti-inflammatory cytokine IL-10. CCL20 binds to CCR6 to promote chemotaxis of lymphocytes and inhibit the proliferation of myeloid progenitors. |
|||
Anti-Mouse CCL-21 Antibody |
|||
| 103-M327 | ReliaTech | 100 µg | 399 EUR |
|
Description: 6Ckine is a novel CC chemokine discovered independently by three groups from the EST database. 6Ckine, also named SLC (secondary lymphoidtissue chemokine), CCL21 and Exodus2, shows 21-33% identity to other CC chemokines. 6Ckine contains the four conserved cysteines characteristic of β chemokines plus two additional cysteines in its unusually long carboxy-lterminal domain. Human 6Ckine cDNA encodes a 134 amino acid highly basic precursor protein with a 23 amino acid residue signal peptide that is cleaved to form the predicted 111 amino acid residue mature protein. Mouse 6Ckine cDNA encodes a 133 amino acid residue protein with a 23 residue signal peptide that is cleaved to generate the 110 residue mature protein. Human and mouse 6Ckine share 86% amino acid sequence identity. 6Ckine is constitutively expressed at high levels in lymphoid tissues such as lymph nodes, spleen and appendix. In mouse, high levels of 6Ckine mRNA are also detected in the lung. Unlike most CC chemokines, 6Ckine is not chemotactic for monocytes. Recombinant mouse 6Ckine is chemotactic in vitro for thymocytes and activated T cells. Recombinant human 6Ckine has been shown to be chemotactic for some human T cell lines, resting PBL, and cultured T cells expanded with PHA and IL2. 6Ckine has also been reported to inhibit hemopoietic progenitor colony formation in a dosedependent manner. 6Ckine acts via the CC receptor CCR7 on T cells and B cells. |
|||
Anti-Mouse CCL-22 Antibody |
|||
| 103-M328 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL22, also known as ABCD1 and MDC (macrophage-derived chemokine), is a CC chemokine cloned from activated mouse B cells. Mouse CCL22 cDNA encodes a precursor protein of 92 amino acid (aa) residues with a 24 aa residue predicted signal peptide that is cleaved to yield a 68 aa residue mature 7.8 kDa protein. At the amino acid sequence level, mouse and human CCL22 share 64% identity and 83% similarity. The genomic organization of the mouse and human CCL22 genes are very similar, exhibiting sequence identity at the intron-exon boundaries. Mouse CCL22 is expressed at high levels in dendritic cells and activated B lymphocytes. Low levels of mouse CCL22 mRNA are also detectable in lung, unstimulated spleen cells, lymph node cells and in thymocytes. CCL22 is a functional ligand for the CC chemokine receptor 4. Recombinant or chemically synthesized mature mouse CCL22 has been shown to induce chemotaxis or Ca2+ mobilization in activated mouse and human T cells. |
|||
Anti-Mouse CCL-24 Antibody |
|||
| 103-M329 | ReliaTech | 100 µg | 399 EUR |
|
Description: Eotaxin2, also named myeloid progenitor inhibitory factor (MPIF2), is a member of the CC chemokine subfamily and is designated CCL24. Eotaxin2 is constitutively expressed in the jejunum and spleen. It can also be induced in the lung by allergen challenge and IL4. LPS and IL4 also differentially regulate the expression of Eotaxin2 in monocytes and macrophages. Mouse Eotaxin2 cDNA encodes a 119 amino acid (aa) precursor protein that shares approximately 58% aa sequence identity with human Eotaxin2. Functionally, Eotaxin2is most closely related to CCL11/Eotaxin and CCL26/Eotaxin3. The three proteins share low sequence homology but have been shown to be potent eosinophil chemoattractants that bind and activate the chemokine receptor CCR3, a receptor that is highly expressed in eosinophils. Eotaxin2 also has the ability to suppress myeloid cell proliferation, a biological function not shared by Eotaxin. |
|||
Anti-Mouse CCL-25 Antibody |
|||
| 103-M330 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL25 (thymus expressed chemokine), also known as TECK (thymus-expressed chemokine), is a CC chemokine that is distantly related (twenty some % amino acid sequence identity) to other CC chemokines. Mouse CCL25 cDNA encodes a 144 amino acid residue precursor protein with a 23 amino acid residue signal peptide that is cleaved to yield a 121 residue mature protein. Mouse CCL25 shares 49% amino acid sequence identity with human CCL25. The expresssion of human and mouse CCL25 was shown to be highly restricted to the thymus and small intestine. Although dendritic cells have been demonstrated to be the source of CCL25 production in the thymus, dendritic cells derived from bone marrow do not express CCL25. The gene for mouse CCL25 has been mapped to chromosome 8. |
|||
Anti-Mouse CCL-27 Antibody |
|||
| 103-M331 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL27, also known as CTACK (cutaneous T cel-lattracting chemokine), ALP, ILC, and ESkine, is a member of the CC family of chemokines. Mature mouse CCL27 is a 95 amino acid (aa) protein that shares 57% aa and 87% aa sequence identity with human and rat CCL27, respectively. It shares 18-31% aa sequence identity with other mouse CC chemokines. An alternately spliced form of mouse CCL27, known as PESKY, is localized to the nucleus and promotes cellular migration. CCL27 is constitutively expressed by keratinocytes and is upregulated by inflammatory stimuli and in wounded skin. CCL27 binds the chemokine receptor CCR10, glycosaminoglycans in the extracellular matrix, sulfated tyrosine residues on PSGL1, and determinants on the surface of fibroblasts and endothelial cells. CCL27 cooperates with CCL17/TARC in inducing the migration of cutaneous lymphocyte antigen (CLA) positive memory T cells to the skin during inflammation. Endothelial cellbound CCL27 can mediate the adhesion of those cells to CLA+ T cells. CCL27 also induces the migration of keratinocyte precursors from bone marrow to the skin, thereby promoting wound healing. In humans, serum CCL27 levels are elevated and correlate with disease severity in atopic dermatitis, psoriasis vulgaris, and mycosis fungoides. |
|||
Anti-Mouse CCL-28 Antibody |
|||
| 103-M332 | ReliaTech | 100 µg | 399 EUR |
|
Description: Mouse CCL28 (CC chemokine ligand 28) is a novel CC chemokine cloned from a Rag1 mouse kidney cDNA library. Mouse CCL28 cDNA encodes a 130 amino acid (aa) precursor protein with a 22 aa signal peptide and a 108 aa mature protein. Mature human and mouse CCL28 share 83% aa identity. Among CC chemokines, CCL28 shares the most homology with CCL27/CTACK. Mouse CCL28 is produced by epithelial cells. Based on Northern blot analysis, it is mainly expressed in testes, kidney and brain. The receptor for CCL28 has been identified as the CCR10, which is also the receptor for CCL27/CTACK. |
|||
Anti-Mouse CCL-1 Antibody |
|||
| 103-M320 | ReliaTech | 100 µg | 399 EUR |
|
Description: Mouse CCL1, also known as TCA3, is a member of the CC beta family of chemokines. The human chemokine I309, which shares approximately 42% amino acid (aa) sequence identity, has been assumed to be the homologue of mouse TCA3. Mouse TCA3 and human I309 also share significant sequence homology in the 5' flanking region of their genes and each contain an extra pair of cysteine residues not found in most other chemokines. CCL1 cDNA encodes a 92 aa residue precursor protein with a predicted 23 aa signal peptide that is cleaved to produce a 69 aa mature protein. The sequence of CCL1 contains one potential Nlinked glycosylation site. Mouse CCL1 is found on the distal portion of mouse chromosome 11 in a cluster with MIP1α, MIP1β and JE. CCL1 acts by binding to the seven transmembrane spanning G-protein coupled receptor, CCR8. CCL1 has been shown to chemoattract T cells. |
|||
Anti-Mouse CCL-2 Antibody |
|||
| 103-M325 | ReliaTech | 100 µg | 399 EUR |
|
Description: Mouse CCL2 is a member of the β (CC) subfamily of chemokines. The mouse CCL2 gene was initially identified as a plateletderived growth factorinducible gene in mouse fibroblasts. Mouse CCL2 cDNA encodes a 148 amino acid (aa) residue with a putative 23 aa signal peptide that is cleaved to generate the mature protein. Mouse CCL2 shares 82% amino acid sequence identity with rat CCL2. Mouse CCL2 also shares 55% amino acid sequence identity with human MCP1. Compared to human MCP1, mouse CCL2 has a 49 aa residue extension at the carboxyterminus. When a DNA sequence encoding the 125 aa residue of the mature CCL2 protein was expressed in E. coli at R&D Systems, the purified protein had the predicted N-terminus but a mass of 8525 Da. The truncation of most of the C terminal extension could be due either to purification artifact or to posttranslational modification. The truncated recombinant CCL2 has a potency similar to that of human MCP1 in the monocyte chemotaxis assay. Mouse CCL2 has full activity on human cells while human MCP1 has limited activity on mouse cells. |
|||
Anti-Mouse CCL-3 Antibody |
|||
| 103-M333 | ReliaTech | 100 µg | 399 EUR |
|
Description: The macrophage inflammatory proteins 1α (or CCL3) and 1β, two closely related but distinct proteins, were originally co purified from medium conditioned by a LPS-stimulated murine macrophage cell line. Mature mouse MIP1α shares approximately 77% and 70% amino acid identity with human MIP1α and mouse MIP1β, respectively. MIP1 proteins are expressed primarily in T cells, B cells, and monocytes after antigen or mitogen stimulation. The MIP1 proteins are members of the β (CC) subfamily of chemokines. Both MIP1α and MIP1β are monocyte chemoattractants in vitro. Additionally, the MIP1 proteins have been reported to have chemoattractant and adhesive effects on lymphocytes, with MIP1α and MIP1β preferentially attracting CD8+ and CD4+ T cells, respectively. MIP1α has also been shown to attract B cells as well as eosinophils. MIP1 proteins have been reported to have multiple effects on hematopoietic precursor cells and MIP1α has been identified as a stem cell inhibitory factor that can inhibit the proliferation of hematopoietic stem cells in vitro as well as in vivo. In the same assays, MIP1β was reported to be much less active. The functional receptor for MIP1α has been identified as CCR1 and CCR5. |
|||
Anti-Mouse CCL-4 Antibody |
|||
| 103-M334 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL4, also known as macrophage inflammatory protein 1 beta (MIP1β), is a 12 kDa β chemokine that is secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells, and pulmonary smooth muscle cells (1, 2). CCL4 attracts a variety of immune cells to sites of microbial infection as well as to other pathologic inflammation such as allergic asthma and ischemic myocardium. A CCL4 deficiency in mice promotes the development of autoantibodies, possibly as a result of compromised regulatory T cell recruitment. CCL4 is secreted from activated monocytes as a heterodimer with CCL3/MIP1α. The first two N-terminal amino acids can be cleaved from human CCL4 by CD26/DPPIV. Both the full length and truncated forms exert biological activity through CCR5, and the truncated form additionally interacts with CCR1 and CCR2. In humans, the ability of CCL4 to bind CCR5 inhibits the cellular entry of Mtropic HIV1 which utilizes CCR5 as a coreceptor. Both forms of CCL4 block HIV1 infection of T cells by inducing the downregulation of CCR5. Mature mouse CCL4 shares 77% and 86% amino acid sequence identity with human and rat CCL4, respectively. |
|||
Anti-Mouse CCL-5 Antibody |
|||
| 103-M335 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL5, also known as RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted), is an 8 kDa βchemokine that plays a primary role in the inflammatory immune response by means of its ability to attract and activate leukocytes. Human and mouse RANTES exhibit cross-species activity on human and mouse cells (4). Mature mouse CCL5 shares 100% amino acid (aa) sequence identity with rat CCL5 and 75-88% with canine, cotton rat, feline, and human CCL5. CCL5 is secreted by many cell types at inflammatory sites, and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4, and CCR5. Inflammatory responses can be impaired by the sequestration of CCL5 by the cytomegalovirus protein US28. In humans, CCR5 binding to CCL5 inhibits the infectivity of R5 (M tropic) but not X4 (T tropic) strains of HIV. The two N-terminal residues of CCL5 can be removed by CD26/DPPIV, generating a protein that functions as a chemotaxis inhibitor and more effectively blocks M tropic HIV 1 infection of monocytes. Oligomerization of CCL5 on glycosaminoglycans is required for CCR1mediated leukocyte adhesion and activation as well as CCL5’s interaction with the chemokine CXCL4/PF4. The deposition of CCL5 on activated vascular endothelial cells is crucial for monocyte adhesion to damaged vasculature, but CCL5 oligomerization is not required for the extravasation of adherent leukocytes. CCL5 is upregulated in breast cancer and promotes tumor progression through the attraction of proinflammatory macrophages in addition to its actions on tumor cells, stromal cells, and the vasculature. |
|||
Anti-Mouse CCL-8 Antibody |
|||
| 103-M337 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL8, also known as Monocyte Chemoattractant Protein 2 (MCP2), is an inflammatory CC chemokine that attracts monocytes, eosinophils and basophils. It is produced by many cell types and signals through interactions with CCR1, CCR2, CCR3 and CCR5. |
|||
Anti-Mouse CCL-9 Antibody |
|||
| 103-M338 | ReliaTech | 100 µg | 399 EUR |
|
Description: Mouse CCL9/10 (also named MIP1γ and MRP2) is an 11 kDa, secreted, monomeric polypeptide that belongs to the β (or CC) intercrine family of chemokines. Based on its activity and amino acid (aa) sequence, it is further classified as a member of the NC6 or six cysteinecontaining CC subfamily of chemokines. This subfamily contains four Nterminally extended chemokines, two human (CCL15 and CCL23) and two mouse (CCL9 and CCL10). Within this subfamily, there are no humanto rodent interspecies orthologs. Mouse CCL9/10 is synthesized as a 122 aa precursor that contains a 21 aa signal sequence and a 101 aa mature region with six cysteines. As noted, the mature region has an expanded Nterminus relative to other CC family members, and it forms a third intrachain disulfide bond with its two extra cysteines. Mouse CCL9/10 is 75% aa identical to rat CCL9/10. Chemokines are known to undergo proteolytic processing to generate multiple isoforms. NC6 chemokines are usually only marginally active at fulllength, but are converted to highly active forms upon Nterminal truncation. Mature CCL9, in the presence of inflammatory fluids, is naturally truncated by 28, 29 or 30 aa at the Nterminus, generating a highly active, 8 kDa, 71 73 aa CCR1 ligand. In contrast, other CCR1 ligands, CCL3/MIP1α and CCL5/RANTES, lose their potency when proteolytically processed. CCL9/10 is constitutively secreted, and circulates as a fulllength molecule. Any onset of inflammation with subsequent enzyme release may act on local NC6 chemokines, generating early, potent leukocyte chemoattractants. |
|||
Mouse RANTES (CCL 5) |
|||
| MBS691610-0005mg | MyBiosource | 0.005mg | 300 EUR |
Mouse RANTES (CCL 5) |
|||
| MBS691610-002mg | MyBiosource | 0.02mg | 450 EUR |
Mouse RANTES (CCL 5) |
|||
| MBS691610-5x002mg | MyBiosource | 5x0.02mg | 1725 EUR |
Mouse Monoclonal anti-human CCL-19 (MIP-3 beta) |
|||
| hAP-0143 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-15 (MIP-1 delta) |
|||
| hAP-0139 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-15 (MIP-1 delta) |
|||
| hAP-0139A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-20 (MIP-3 alpha) |
|||
| hAP-0145 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-4 (MIP-1 beta) |
|||
| hAP-1166 | Angio Proteomie | 100ug | 250 EUR |
Mouse CCL-5 ELISA Kit |
|||
| EMC0240 | Abclonal | 96Tests | 625.2 EUR |
Mouse Monoclonal anti-human CCL-3 (MIP-1 alpha) |
|||
| hAP-0154 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-3 (MIP-1 alpha) |
|||
| hAP-0154A | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human CCL-3 (MIP-1 alpha) |
|||
| hAP-0154B | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-28 |
|||
| mAP-0179 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-3 |
|||
| mAP-0180 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-4 |
|||
| mAP-0181 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-5 |
|||
| mAP-0182 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-8 |
|||
| mAP-0184 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-9 |
|||
| mAP-0185 | Angio Proteomie | 100ug | 250 EUR |
Eotaxin / CCL-11 (Mouse) - ELISA Kit |
|||
| EK-033-40 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
Rat Monoclonal anti-mouse CCL-22 (MDC) |
|||
| mAP-0175 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-17 (TARC) |
|||
| mAP-0170 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-25 (TECK) |
|||
| mAP-0177 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-27 (CTACK) |
|||
| mAP-0178 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-21 (6Ckine) |
|||
| mAP-0174 | Angio Proteomie | 100ug | 250 EUR |
Rat Monoclonal anti-mouse CCL-11 (Eotaxin) |
|||
| mAP-0168 | Angio Proteomie | 100ug | 250 EUR |
Anti-Human CCL-11 Antibody |
|||
| 101-M161 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL11 is a potent eosinophil chemoattractant that was originally purified from bronchoalveolar lavage fluid of guinea pigs sensitized by aerosol challenge with ovalbumin. Microsequencing of the purified protein revealed the guinea pig CCL11 to be a member of the beta (CC) chemokine family of inflammatory and immunoregulatory cytokines. cDNA clones for guinea pig, mouse, and human CCL11 have been isolated. Human CCL11 cDNA encodes a 97 amino acid residue precursor protein from which the aminoterminal 23 amino acid residues are cleaved to generate the 74 amino acid residue mature human CCL11. At the protein sequence level, mature human CCL11 is approximately 60% identical to mature mouse and guinea pig CCL11. In addition, human CCL11 also shows high amino acid sequence identity to human MCP1, 2, and 3. Human CCL11 is chemotactic for eosinophils, but not mononuclear cells or neutrophils. The CC chemokine receptor 3 (CCR3) has now been identified to be a specific human CCL11 receptor. CCR3 has also been shown to serve as a cofactor for a restricted subset of primary HIV viruses and binding of CCL11 to CCR3 inhibited infection by the HIV isolates. |
|||
Anti-Human CCL-14 Antibody |
|||
| 101-M162 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL14 is a chemokine that promotes chemotaxis of T cells, monocytes, and eosinophils. It occurs in two isoforms resulting from differential mRNA splicing. Following cleavage of a 19 amino acid signal peptide, mature CCL14a (aa 20-93) is a 74 amino acid peptide that is also known as HCC1 (Hemofiltrate CC Chemokine1). It is a weak CCR1 agonist, however, an 8 amino acid Nterminal truncation (aa 28 93) allows potent signaling through CCR1 and CCR5. CCL14b, also called HCC3, is a 90 amino acid peptide (aa 20-109) resulting from the insertion of 16 amino acids between residues 7 and 8 of CCL14a. |
|||
Anti-Human CCL-15 Antibody |
|||
| 101-M163 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL15, a human CC chemokine, was isolated from a human fetal spleen cDNA library. CCL15 cDNA encodes a predicted 113 amino acid (aa) protein containing a putative signal peptide of 21 aa that is cleaved to generate a 92 aa residue mature protein. Within the CC family members, human CCL15 shares 45%, 44%, 35%, and 30% aa homology with mouse C10, human MPIF1, human HCC1, and mouse MIP1γ, respectively. The gene for MIP1δ is found on chromosome 17 where the genes for most of the human CC chemokines are located. Human CCL15 is expressed in T and B lymphocytes, NK cells, monocytes and monocytederived dendritic cells. Human MIP1δ is chemotactic for T cells and monocytes and has been shown to induce calcium flux in human CCR1transfected cells. |
|||
Anti-Human CCL-28 Antibody |
|||
| 101-M185 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL-28 or MEC is a secreted CC chemokine expressed primarily by epithelial cells of the bronchioles, salivary gland, mammary gland and colon. MEC signals through the CCR10 receptor and chemoattracts resting CD4, CD8 T-cells and eosinophils. MEC contains six cysteines including the four highly conserved cysteine residues present in CC chemokines. Recombinant human MEC is a 12.3 kDa protein containing 108 amino acid residues. |
|||
Anti-Human CCL-14 Antibody |
|||
| 101-M246 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL14 is a chemokine that promotes chemotaxis of T cells, monocytes, and eosinophils. It occurs in two isoforms resulting from differential mRNA splicing. Following cleavage of a 19 amino acid signal peptide, mature CCL14a (aa 20-93) is a 74 amino acid peptide that is also known as HCC1 (Hemofiltrate CC Chemokine1). It is a weak CCR1 agonist, however, an 8 amino acid Nterminal truncation (aa 28 93) allows potent signaling through CCR1 and CCR5. CCL14b, also called HCC3, is a 90 amino acid peptide (aa 20-109) resulting from the insertion of 16 amino acids between residues 7 and 8 of CCL14a. |
|||
Anti-Human CCL-11 Antibody |
|||
| 101-M256 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL11 is a potent eosinophil chemoattractant that was originally purified from bronchoalveolar lavage fluid of guinea pigs sensitized by aerosol challenge with ovalbumin. Microsequencing of the purified protein revealed the guinea pig CCL11 to be a member of the beta (CC) chemokine family of inflammatory and immunoregulatory cytokines. cDNA clones for guinea pig, mouse, and human CCL11 have been isolated. Human CCL11 cDNA encodes a 97 amino acid residue precursor protein from which the aminoterminal 23 amino acid residues are cleaved to generate the 74 amino acid residue mature human CCL11. At the protein sequence level, mature human CCL11 is approximately 60% identical to mature mouse and guinea pig CCL11. In addition, human CCL11 also shows high amino acid sequence identity to human MCP1, 2, and 3. Human CCL11 is chemotactic for eosinophils, but not mononuclear cells or neutrophils. The CC chemokine receptor 3 (CCR3) has now been identified to be a specific human CCL11 receptor. CCR3 has also been shown to serve as a cofactor for a restricted subset of primary HIV viruses and binding of CCL11 to CCR3 inhibited infection by the HIV isolates. |
|||
Anti-Human CCL-13 Antibody |
|||
| 101-M257 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL13, also known as Monocyte Chemoattractant Protein4 (MCP4), is a CC chemokine that acts as a chemoattractant for monocytes, eosinophils and T cells and as an activator of basophils. Human CCL13 cDNA encodes a 98 amino acid residue precursor protein with a 23 amino acid residue hydrophobic signal peptide that is cleaved to yield an 8 kDa, 75 aa mature CCL13. Mature CCL13 lacks any potential N-glycosylation sites and shares a pyroglutamate proline motif with other human MCP proteins. Human CCL13 is most homologous to MCP1, 3 and Eotaxin, exhibiting approximately 65-66% amino acid sequence identity. CCL13 mRNA is expressed by a number of activated cell types, including endothelial cells, macrophages, bronchial epithelium and type II alveolar cells, and perhaps lymphocytes. The bioactivities of CCL13 are mediated by the CC chemokine receptors CCR2 and CCR3. |
|||
Anti-Human CCL-15 Antibody |
|||
| 101-M258 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL15, a human CC chemokine, was isolated from a human fetal spleen cDNA library. CCL15 cDNA encodes a predicted 113 amino acid (aa) protein containing a putative signal peptide of 21 aa that is cleaved to generate a 92 aa residue mature protein. Within the CC family members, human CCL15 shares 45%, 44%, 35%, and 30% aa homology with mouse C10, human MPIF1, human HCC1, and mouse MIP1γ, respectively. The gene for MIP1δ is found on chromosome 17 where the genes for most of the human CC chemokines are located. Human CCL15 is expressed in T and B lymphocytes, NK cells, monocytes and monocytederived dendritic cells. Human MIP1δ is chemotactic for T cells and monocytes and has been shown to induce calcium flux in human CCR1transfected cells. |
|||
Anti-Human CCL-16 Antibody |
|||
| 101-M259 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL16, also known as HCC-4, is a CC chemokine that interacts with CCR1, CCR2, and CCR5. CCL16 is expressed weakly by NK cells, γδ T cells, and some T cells and is upregulated in monocytes by IL-10. CCL16 functions as a chemoattractant for monocytes and promotes the maturation of monocyte derived dendritic cells. |
|||
Anti-Human CCL-17 Antibody |
|||
| 101-M260 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL17 is a novel CC chemokine identified using a signal sequence trap method. CCL17 cDNA encodes a highly basic 94 amino acid (aa)residue precursor protein with a 23 aa residue signal peptide that is cleaved to generate the 71 aa residue mature secreted protein. Among CC chemokine family members, CCL17 has approximately 24-29% amino acid sequence identity with RANTES, MIP1α, MIP1β, MCP1, MCP2, MCP3, and I309. The gene for human CCL17 has been mapped to chromosome 16q13 rather than chromosome 17 where the genes for many human CC chemokines are clustered. CCL17 is constitutively expressed in thymus, and at a lower level in lung, colon, and small intestine. CCL17 is also transiently expressed in stimulated peripheral blood mononuclear cells. Recombinant CCL17 has been shown to be chemotactic for T cell lines but not monocytes or neutrophils. CCL17 was identified to be a specific functional ligand for CCR4, a receptor that is selectively expressed on T cells. |
|||
Anti-Human CCL-18 Antibody |
|||
| 101-M261 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL18, also known as PARC (Pulmonary and Activation-regulated Chemokine), is expressed by monocyte-derived dendritic cells and Th2 cytokine-stimulated macrophages. It functions as a chemoattractant for naïve T cells but not monocytes or neutrophils. |
|||
Anti-Human CCL-19 Antibody |
|||
| 101-M262 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL19, also known as MIP3β and ELC (EBI1Ligand Chemokine), is a 77 amino acid (aa) β chemokine that is distantly related to other β chemokines (20-30% aa sequence identity). The gene for MIP3β has been mapped to chromosome 9p13 rather than chromosome 17 where the genes for many human β chemokines are clustered. MIP3β is constitutively expressed in various lymphoid tissues (including thymus, lymph nodes, appendix and spleen). The expression of MIP3β is downregulated by the antiinflammatory cytokine IL10. Recombinant MIP3β is chemotactic for cultured human lymphocytes. MIP3β is a ligand for CCR7 (previously referred to as the EpsteinBarr virus-induced gene 1 (EBI1) orphan receptor), a chemokine receptor that is expressed in various lymphoid tissues and activated B and T lymphocytes. CCR7 is strongly upregulated in B cells infected with EpsteinBarr virus and T cells infected with herpesvirus 6 or 7. |
|||
Anti-Human CCL-20 Antibody |
|||
| 101-M264 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL20, also known as LARC (Liver and Activation-regulated Chemokine) and as Exodus, is one of many novel β chemokines identified through bioinformatics. CCL20 cDNA encodes a 96 amino acid (aa) residue precursor protein with a 26 aa residue signal peptide that is predicted to be cleaved to form the 70 aa residue mature secreted protein. CCL20 is distantly related to other β chemokines (20-28% aa sequence identity) and the gene for CCL20 has been mapped to chromosome 2 rather than 17. CCL20 has been shown to be expressed predominantly in lymph nodes, appendix, PBL, fetal liver, fetal lung and several cell lines. The expression of CCL20 is strongly upregulated by inflammatory signals and downregulated by the anti-inflammatory cytokine IL10. Synthetic or recombinant CCL20 has been shown to be chemotactic for lymphocytes and to inhibit proliferation of myeloid progenitors in colony formation assays. CCL20 has now been shown to be a unique functional ligand for CCR6 (previously referred to as GPRCY4, CKRL3, or STRL22 orphan receptor), a chemokine receptor that is selectively and highly expressed in human dendritic cells derived from CD34+ cord blood precursors. |
|||
Anti-Human CCL-21 Antibody |
|||
| 101-M265 | ReliaTech | 100 µg | 399 EUR |
|
Description: 6Ckine or CCL-21 is a novel CC chemokine discovered independently by three groups from the EST database. 6Ckine, also named SLC (Secondary Lymphoid-tissue Chemokine), CCL21 and Exodus2, shows 21 33% identity to other CC chemokines. 6Ckine contains the four conserved cysteines characteristic of β chemokines plus two additional cysteines in its unusually long carboxy-lterminal domain. Human 6Ckine cDNA encodes a 134 amino acid residue, highly basic, precursor protein with a 23 amino acid residue signal peptide that is cleaved to form the predicted 111 amino acid residue mature protein. Mouse 6Ckine cDNA encodes a 133 amino acid residue protein with a 23 residue signal peptide that is cleaved to generate the 110 residue mature protein. Human and mouse 6Ckine are highly conserved, exhibiting 86% amino acid sequence identity. 6Ckine is constitutively expressed at high levels in lymphoid tissues such as lymph nodes, spleen and appendix. In mouse, high levels of 6Ckine mRNA are also detected in the lung. The gene for human 6Ckine has been localized at human chromosome 9p13 rather than chromosome 17 where the genes of many human CC chemokines are clustered. The 6Ckine gene location is within a region of about 100 kb from the gene for MIP3β/ ELC, another novel CC chemokine. |
|||
Anti-Human CCL-22 Antibody |
|||
| 101-M266 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL22, also named stimulated T cell chemotactic protein (STCP1) and MDC, is a CC chemokine initially isolated from clones of monocytederived macrophages. Human CCL22 cDNA encodes a precursor protein of 93 amino acid residues with a 24 amino acid residue predicted signal peptide that is cleaved to yield a 69 amino acid residue mature 8 kDa protein. At the amino acid sequence level, CCL22 shows less than 35% identity to other CC chemokine family members. Human CCL22 is expressed in dendritic cells, macrophages and activated monocytes. In addition, CCL22 expression is also detected in the tissues of thymus, lymph node and appendix. The gene for human CCL22 has been mapped to chromosome 16 rather than chromosome 17 where the genes for many human CC chemokines are clustered. Recombinant or chemically synthesized mature CCL22 has been shown to induce chemotaxis or Ca2+ mobilization in dendritic cells, IL2 activated NK cells, and activated T lymphocytes. A CD8+ T lymphocytederived secreted soluble activity that suppresses infection by primary non-syncytium-inducing and syncytium-inducing HIV1 isolates and the T cell lineadapted isolate HIV1 IIIB, has been identified as CCL22. Based on aminoterminal sequence analysis, the major CD8 + T lymphocyte-derived CCL22 protein yielded an amino-terminal sequence of YGANM, which is two amino acid residues shorter than the predicted mature CCL22. The difference in potency between the two mature CCL22 isoforms has not been determined. |
|||
Anti-Human CCL-23 Antibody |
|||
| 101-M267 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL23, also known as Myeloid Progenitor Inhibitory Factor1 (MPIF1), is a CC chemokine that is produced by some myeloid cell lines and monocytederived dendritic cells. It binds CCR1 and inhibits the differentiation of progenitor cells that give rise to granulocytes and macrophages. CCL23 is also chemotactic for resting T cells, neutrophils, monocytes and dendritic cells. |
|||
Anti-Human CCL-24 Antibody |
|||
| 101-M268 | ReliaTech | 100 µg | 399 EUR |
|
Description: Eotaxin2, also named MPIF2 and Ckβ6, is a CC chemokine that is designated CCL24. Eotaxin2 cDNA encodes a 10.5 kDa, 119 amino acid residue precursor protein with a 26 aa residue signal peptide that is cleaved to generate a mature protein predicted to contain 93 amino acid residues with an N-glycosylation site. C-terminally truncated variants with 78, 73, 75 and 76 residues have also been described. Eotaxin 2 shares 40%, 42% and 39% amino acid sequence identity with other CC chemokines CCL7/MCP3, CCL3/MIP1α, and CCL11/Eotaxin, respectively. Eotaxin2 mRNA is weakly expressed in activated monocytes and T lymphocytes. Recombinant Eotaxin2 induces chemotaxis of eosinophils, basophils, and resting T lymphocytes, but not monocytes or activated T lymphocytes. Eotaxin2 also suppresses colony formation by high proliferative multipotential hematopoietic progenitors. On eosinophils, the effects of Eotaxin2, Eotaxin and CCL13/MCP4 are mediated by the receptor CCR3. |
|||
Anti-Human CCL-25 Antibody |
|||
| 101-M269 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL25 (thymus-expressed chemokine) is a CC chemokine that is distantly related (approximately 20% amino acid sequence identity) to other CC chemokines. Human CCL25 cDNA encodes a 150 aa precursor protein with a 23 aa signal peptide that is cleaved to yield a 127 aa mature protein. Mouse CCL25 cDNA has also been cloned and shown to encode a 144 aa protein that exhibits 49% aa sequence identity to human CCL25. The expresssion of human and mouse CCL25 was shown to be highly restricted to the thymus and small intestine. Although dendritic cells have been demonstrated to be the source of CCL25 production in the thymus, dendritic cells derived from bone marrow do not express CCL25. The gene for mouse CCL25 has been mapped to chromosome 8 rather than chromosome 11 where many mouse CC chemokines are clustered. Recombinant human and mouse CCL25 are chemotactic for activated macrophages, dendritic cells and thymocytes. CCL25 is also a specific agonist for the CCR9 chemokine receptor. |
|||
Anti-Human CCL-26 Antibody |
|||
| 101-M270 | ReliaTech | 100 µg | 399 EUR |
|
Description: Eotaxin-3 is a CC chemokine that signals through the CCR3 receptor. It is produced by endothelial cells stimulated with IL-4 or IL-13. Eotaxin-3 selectively targets cells expressing CCR3, including eosinophils, basophils, T cells and monocytes. Eotaxin-3 has similar activity to Eotaxin and Eotaxin-2, but the three Eotaxins share only a low degree of sequence homology. Recombinant human Eotaxin-3 is an 8.4 kDa protein containing 71 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
|||
Anti-Human CCL-27 Antibody |
|||
| 101-M271 | ReliaTech | 100 µg | 399 EUR |
|
Description: CTACK or CCL-27 is a keratinocyte-derived CC chemokine which signals through the CCR10 receptor. Both CTACK and CCR10 are expressed in normal and irritated epithelial cells. CTACK selectively attracts CLA+ T-cells and directs them into the skin. CTACK contains the four highly conserved cysteine residues present in most CC chemokines. The mature protein contains 88 amino acid residues. Recombinant human CTACK is a 10.2 kDa protein containing 88 amino acid residues. |
|||
Anti-Human CCL-28 Antibody |
|||
| 101-M272 | ReliaTech | 100 µg | 399 EUR |
|
Description: CCL-28 or MEC is a secreted CC chemokine expressed primarily by epithelial cells of the bronchioles, salivary gland, mammary gland and colon. MEC signals through the CCR10 receptor and chemoattracts resting CD4, CD8 T-cells and eosinophils. MEC contains six cysteines including the four highly conserved cysteine residues present in CC chemokines. Recombinant human MEC is a 12.3 kDa protein containing 108 amino acid residues. |
|||
Anti-Human CCL-1 Antibody |
|||
| 101-M255 | ReliaTech | 100 µg | 399 EUR |
|
Description: ccbe1 is not expressed in endothelial cells of lymph vessels, and it may be a component of the extracellular matrix. In zebrafish, ccbe1 expression was observed along the earliest migration routes of endothelial cells that sprout from the posterior cardinal vein and migrate circuitously before developing into lymphatic vessels. ccbe1 might therefore be involved in guidance of these migrating cells. |
|||